Deborah H. Fuller

Orlance, Inc.

NIH Rank #4056
  • R01 Holder
  • Multi-Institutional
  • Early Career
  • Diverse Portfolio

NIH Funding · FY2024

Total Funding
$2.3M
Fiscal year 2024
Grants Awarded
4
Active NIH grants
National Rank
#4,056
Among 57,894 PIs
First NIH Award
2024
Year of first funding

Funding & rank history

NIH funding totals and national rank by fiscal year.

Single fiscal year on record (FY2024): $2.3M across 4 grants · National rank #4056.

Top grants by award amount

Deborah H. Fuller's NIH grant portfolio, ranked by award amount.

  • 5R44AI179440-02R44
    Clinic-Ready MACH-1 Gene Gun for delivery of a universal influenza DNA vaccine
    $990.3K
    award amount
  • 5R01AI160052-04R01
    De Novo Design of Minibinder Antagonists for COVID-19 and Future Pandemics
    $692.1K
    award amount
  • 5U19AI166058-03U19
    Early in vivo Expressed Antigens and their Role in Virulence, Immune Response, and Vaccines for Coccidioidomycosis
    $363.1K
    award amount
  • 1R44AI186932-01R44
    Enhanced Seasonal Influenza Vaccine Targeting Variable and Conserved Antigens
    $300K
    award amount

Affiliations

Institutions that have administered grants for Deborah H. Fuller.

Career milestones

Key NIH funding milestones over time.

  1. 2024
    First NIH Award
    Orlance, Inc.
  2. 2024
    $500K Cumulative Funding
  3. 2024
    $1M Cumulative Funding
  4. 2024
    $2M Cumulative Funding
  5. 2024
    Entered Top 50% Nationally
    Ranked #4056
  6. 2024
    Entered Top 25% Nationally
    Ranked #4056
  7. 2024
    Multi-Institutional Research
    Awards at 3 institutions

Related investigators

Other NIH-funded PIs frequently associated with Deborah H. Fuller.